X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
animals (8) 8
mice (8) 8
viruses (8) 8
humans (7) 7
virology (7) 7
expression (6) 6
lymphocytes (6) 6
medicine, research & experimental (6) 6
transduction, genetic (5) 5
vsv-gp (5) 5
biotechnology & applied microbiology (4) 4
cells (4) 4
genetic vectors (4) 4
genetics & heredity (4) 4
immunotherapy (4) 4
oncology (4) 4
oncolysis (4) 4
stomatitis (4) 4
vesicular stomatitis-virus (4) 4
abstracts (3) 3
bone marrow (3) 3
cell line (3) 3
cell lines (3) 3
effectiveness (3) 3
flow cytometry (3) 3
gene expression (3) 3
genetic therapy - methods (3) 3
health aspects (3) 3
hiv infections - genetics (3) 3
hiv infections - therapy (3) 3
immunity (3) 3
interferon (3) 3
lymphocytes t (3) 3
melanoma (3) 3
mice, inbred c57bl (3) 3
mice, inbred nod (3) 3
mice, scid (3) 3
neutralizing antibodies (3) 3
oncolytic virus (3) 3
original (3) 3
original article (3) 3
t cells (3) 3
tumors (3) 3
vesicular stomatitis virus (3) 3
activation (2) 2
alpha-dystroglycan (2) 2
animal models (2) 2
article (2) 2
blood (2) 2
cancer (2) 2
cd4-positive t-lymphocytes - metabolism (2) 2
cd4-positive t-lymphocytes - virology (2) 2
cd8 antigen (2) 2
cell line, tumor (2) 2
cell survival (2) 2
cells, cultured (2) 2
drug discovery (2) 2
gene therapy (2) 2
gene-expression (2) 2
genetic therapy (2) 2
genetic vectors - genetics (2) 2
genetically modified organisms (2) 2
genetics (2) 2
glycoprotein (2) 2
glycoproteins (2) 2
hiv (2) 2
hiv vaccine (2) 2
human-immunodeficiency-virus (2) 2
immunodeficiency-virus (2) 2
immunology (2) 2
in-vivo (2) 2
inhibition (2) 2
inhibitors (2) 2
injections, intraperitoneal (2) 2
lentivirus - genetics (2) 2
life sciences (2) 2
lymphocytic choriomeningitis virus (2) 2
medicine (2) 2
metastases (2) 2
mice, inbred balb c (2) 2
mice, knockout (2) 2
microbiology (2) 2
molecular biology (2) 2
molecular medicine (2) 2
neurovirulence (2) 2
pharmacology (2) 2
protection (2) 2
receptor (2) 2
remission (2) 2
replication (2) 2
resistance (2) 2
survival (2) 2
t-cells (2) 2
t-lymphocytes - cytology (2) 2
therapy (2) 2
transplantation (2) 2
transplantation, heterologous (2) 2
tumor (2) 2
vaccination - methods (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Therapy, ISSN 1525-0016, 08/2016, Volume 24, Issue 8, pp. 1423 - 1434
Recent clinical trials with chimeric antigen receptor (CAR) redirected T cells targeting CD19 revealed particular efficacy in the treatment of... 
MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | PROTECTION | LINEAGES | CD28 COSTIMULATION | ADVANCED HODGKINS-LYMPHOMA | SPACER DOMAIN | SOLUBLE CD30 | IMMUNOTHERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | EXPRESSION | LYMPHOCYTES | Original
Journal Article
Vaccines, ISSN 2076-393X, 09/2019, Volume 7, Issue 3, p. 119
Extensive research on generating an efficient HIV vaccine is ongoing. A major aim of HIV vaccines is the induction of long-lasting, broadly neutralizing... 
neutralizing antibodies | viral vector vaccine | Env | HIV vaccine
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2019, Volume 121, Issue 8, pp. 647 - 658
Background Oncolytic virotherapy is thought to result in direct virus-induced lytic tumour killing and simultaneous activation of innate and tumour-specific... 
Immunohistochemistry | Flow cytometry | CD8 antigen | Lung cancer | Viruses | Activation | Lymphocytes T | Gene expression | Progeny | Stomatitis | Lymphocytes | Oncolysis | Interferon | Enzyme-linked immunosorbent assay | Tumors | Immune system
Journal Article
Viruses, ISSN 1999-4915, 03/2018, Volume 10, Issue 3, p. 108
Previously, we described VSV-GP, a modified version of the vesicular stomatitis virus, as a non-neurotoxic oncolytic virus that is effective for the treatment... 
Vesicular stomatitis virus | Oncolytic virus | Melanoma | VSV-GP | IMMUNITY | DEFECTS | vesicular stomatitis virus | melanoma | VIROTHERAPY | INTERFERON | THERAPY | VIROLOGY | PATHWAY | oncolytic virus | INHIBITORS | VESICULAR STOMATITIS-VIRUS | BLOCKADE | NIVOLUMAB PLUS IPILIMUMAB | Index Medicus
Journal Article
Molecular Therapy, ISSN 1525-0016, 08/2016, Volume 24, Issue 8, pp. 1423 - 1434
Recent clinical trials with chimeric antigen receptor (CAR) redirected T cells targeting CD19 revealed particular efficacy in the treatment of... 
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2018, Volume 143, Issue 7, pp. 1786 - 1796
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 8, p. e12357
Although a variety of genetic strategies have been developed to inhibit HIV replication, few direct comparisons of the efficacy of these inhibitors have been... 
HEMATOPOIETIC-CELLS | IMMUNODEFICIENCY-VIRUS | LENTIVIRAL VECTOR | BIOLOGY | GENE-EXPRESSION | ANTIRETROVIRAL THERAPY | MODIFIED T-CELLS | GP41-DERIVED PEPTIDES | CCR5 | LYMPHOCYTES | DELIVERY | Genetic Therapy | Recombinant Fusion Proteins - pharmacology | Species Specificity | Virus Replication - genetics | Humans | Virus Internalization - drug effects | Recombinant Fusion Proteins - metabolism | HIV Fusion Inhibitors - metabolism | HIV-1 - physiology | Cell Membrane - metabolism | CD4-Positive T-Lymphocytes - virology | Cell Line | Virus Replication - drug effects | Gene Expression | Transduction, Genetic | Cell Survival | HIV-1 - drug effects | CD4-Positive T-Lymphocytes - cytology | HIV Infections - genetics | CD4-Positive T-Lymphocytes - metabolism | HIV Fusion Inhibitors - pharmacology | Animals | HIV Infections - therapy | Recombinant Fusion Proteins - genetics | Mice | RNA, Antisense - genetics | RNA | Analysis | Genetically modified organisms | Development and progression | T cells | Gene therapy | HIV (Viruses) | Health aspects | HIV infection | Natural selection | Populations | Transplants & implants | Peptides | Positive selection | Viruses | Infections | Lymphocytes T | Medical schools | Proteins | Immunology | Lymphocytes | Human immunodeficiency virus--HIV | Bone marrow | Clonal selection | Inhibition | Drug therapy | Genetic modification | Antiretroviral drugs | Membrane fusion | Cell survival | Effectiveness | Antisense RNA | Cultures | Glycoproteins | Gene expression | Ribonucleic acid--RNA | Survival | CD4 antigen | Tat protein | Inhibitors | Cell lines | Replication | In vivo methods and tests | Ribonucleic acid | HIV | Human immunodeficiency virus
Journal Article
Vaccines, ISSN 2076-393X, 07/2019, Volume 7, Issue 3, p. 59
The respiratory syncytial virus (RSV) is one major cause of lower respiratory tract infections in childhood and an effective vaccine is still not available. We... 
respiratory syncytial virus (RSV) | neutralizing antibodies | viral vector vaccine | VSV-GP
Journal Article
Journal Article
Molecular Therapy - Oncolytics, ISSN 2372-7705, 2016, Volume 3, Issue C, p. 16021
Previously, we described an oncolytic vesicular stomatitis virus variant pseudotyped with the nonneurotropic glycoprotein of the lymphocytic choriomeningitis... 
MEDICINE, RESEARCH & EXPERIMENTAL | ALPHA-DYSTROGLYCAN | CELLS | VIROTHERAPY | ONCOLOGY | GLIOMA | INFECTIVITY | RECEPTOR | VESICULAR STOMATITIS-VIRUS | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | EXPRESSION | CHEMOTHERAPY
Journal Article
JOURNAL OF VIROLOGY, ISSN 0022-538X, 09/2019, Volume 93, Issue 18
Neutralization by antibodies and complement limits the effective dose and thus the therapeutic efficacy of oncolytic viruses after systemic application. We and... 
ENVELOPED VIRUSES | neutralization | vesicular stomatitis virus | VSV-GP | N-GLYCOLYLNEURAMINIC ACID | IGG | NATURAL ANTIBODY | HUMAN-IMMUNODEFICIENCY-VIRUS | INACTIVATION | GAL | VIROLOGY | oncolytic virus | xenoantigens | HUMORAL IMMUNITY | RESISTANCE | complement
Journal Article